Literature DB >> 19157919

The use of corticosteroids and nonsteroidal antiinflammatory medication for the management of pain and inflammation after third molar surgery: a review of the literature.

King Kim1, Pardeep Brar, Jesse Jakubowski, Steven Kaltman, Eustorgio Lopez.   

Abstract

The use of medication to relieve pain and inflammation after removal of third molars has been explored thoroughly in the literature. Narcotic analgesics, nonsteroidal antiinflammatory drugs (NSAIDs), corticosteroids, and combinations of these all have a role in the postoperative management of pain and swelling within this group of patients. This article addresses the use of NSAIDs and corticosteroids after third molar surgery, along with a review of the literature, which is incorporated to provide practitioners helpful, quick, and reliable information regarding patients undergoing third molar surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157919     DOI: 10.1016/j.tripleo.2008.11.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  43 in total

Review 1.  Pre- and postoperative management techniques. Before and after. Part 2: the removal of third molars.

Authors:  J Mansoor
Journal:  Br Dent J       Date:  2015-03-13       Impact factor: 1.626

2.  Intravenous lidocaine for effective pain relief after bimaxillary surgery.

Authors:  Uilyong Lee; Young-Jun Choi; Geun Joo Choi; Hyun Kang
Journal:  Clin Oral Investig       Date:  2017-02-06       Impact factor: 3.573

3.  Influence of Kinesiologic Tape on Post-operative Swelling After Orthognathic Surgery.

Authors:  U Tozzi; M Santagata; A Sellitto; G P Tartaro
Journal:  J Maxillofac Oral Surg       Date:  2015-03-29

4.  Efficacy of low-level laser therapy in the management of pain, facial swelling, and postoperative trismus after a lower third molar extraction. A preliminary study.

Authors:  Marta López-Ramírez; Miguel Angel Vílchez-Pérez; Jordi Gargallo-Albiol; Josep Arnabat-Domínguez; Cosme Gay-Escoda
Journal:  Lasers Med Sci       Date:  2011-05-27       Impact factor: 3.161

Review 5.  Controlled release drug delivery systems to improve post-operative pharmacotherapy.

Authors:  Prabhat Bhusal; Jeff Harrison; Manisha Sharma; David S Jones; Andrew G Hill; Darren Svirskis
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

6.  Pre-emptive effect of dexamethasone injection and consumption on post-operative swelling, pain, and trismus after third molar surgery. A prospective, double blind and randomized study.

Authors:  Pradeep D Chaudhary; Sanjay Rastogi; Prashant Gupta; B Niranjanaprasad Indra; Roy Thomas; Rupshikha Choudhury
Journal:  J Oral Biol Craniofac Res       Date:  2015-03-05

7.  A comparative study of the effect of two dosages of submucosal injection of dexamethasone on postoperative discomfort after third molar surgery: a prospective randomized study.

Authors:  Srimathy S Arora; Tanvi Phull; Ish Kumar; Arun Kumar; Nilesh Kumar; Hem Singh
Journal:  Oral Maxillofac Surg       Date:  2018-05-12

8.  A Comparative Study of the Effect of Prednisolone and Celecoxib on MMO (Maximum Mouth Opening) and Pain Following Removal of Impacted Mandibular Third Molars.

Authors:  Ali Akbar Moghaddamnia; Kamran Nosrati; Mohammad Mehdizadeh; Shabnam Milani; Maral Aghvami
Journal:  J Maxillofac Oral Surg       Date:  2012-08-24

9.  Comparison of the anti-inflammatory effect of dexamethasone and ketorolac in the extractions of third molars.

Authors:  Janayna Gomes Paiva-Oliveira; Paulo Roberto Haidamus Oliveira Bastos; Elenir R J Cury Pontes; Júlio César Leite da Silva; Jéssica Andréa Berto Delgado; Nelson Talatoci Oshiro-Filho
Journal:  Oral Maxillofac Surg       Date:  2015-11-16

10.  Therapeutic elastic tape reduces morbidity after wisdom teeth removal--a clinical trial.

Authors:  Oliver Ristow; Bettina Hohlweg-Majert; Stephen R Stürzenbaum; Victoria Kehl; Steffen Koerdt; Lilian Hahnefeld; Christoph Pautke
Journal:  Clin Oral Investig       Date:  2013-08-21       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.